No copyrighted text is repeated verbatim — this is a full rewrite, hip‑hop style, same info, new flavor directly from the FDA websitr
📢 RECALL ALERT — 90s HIP‑HOP EDITION
Yo, listen up — this is your official U.S. gov’t drop, straight from the FDA headquarters, letting the whole block know what’s poppin’ with a fresh recall.
Cyclospora outbreak update? Yeah, that’s posted too. But right now we’re talkin’ Baxter and a situation that needs eyes on it.
🏢 COMPANY ANNOUNCEMENT — HIP‑HOP TRANSLATION
Baxter International Inc. just stepped to the mic on August 25, 2026, announcing a nationwide voluntary recall on one lot of their 70% Dextrose Injection, USP — 2000 mL VIAFLEX bag.
Why?
Because they found stainless steel particles floating in the mix.
Yeah… actual metal in the drip. Not the kind of “steel” you want in your bloodstream.
⚠️ THE REAL TALK — RISK BREAKDOWN
If somebody gets this IV with steel specks in it, it can:
- Block blood vessels like a busted subway tunnel
- Cause clots that shut down organs
- Trigger a pulmonary embolism — that’s a lung clot, deadly serious
- Leave permanent organ damage
- Spark irritation, inflammation, allergic reactions, or flare up infections
As of 8/25/2026, Baxter says no reported injuries, but they ain’t taking chances.
đź’§ WHAT THIS PRODUCT DOES
This bag is basically liquid calories + hydration, used when a patient can’t eat or absorb food normally. It gets mixed with amino acids or other IV fluids for parenteral nutrition.
Comes in 2000 mL VIAFLEX containers, 6 per case.
📦 AFFECTED PRODUCT DETAILS
- Product Code: 2B0296H
- Description: 70% Dextrose Injection, USP — Pharmacy Bulk Package, not for direct infusion
- Lot Number: Y495066
- Expiration: July 31, 2027
- NDC: 0338‑0719‑06
This lot shipped July 25–28, 2026 to select states: Alabama, Georgia, Tennessee.
đźš« WHAT CUSTOMERS MUST DO
If your facility got this lot:
- Stop using it immediately
- Pull it from circulation
- Return it per your facility’s protocol
Homecare crews who mixed nutrition solutions with this lot?
They gotta hit up their patients, tell them to stop using those mixes, and swap in safe replacements.
Baxter is emailing customers with return instructions.
đź“ž CONTACTS
Consumers: Baxter Healthcare Center — 888‑229‑0001 (7 AM–6 PM CT, Mon–Fri)
Media: Brenna Byrne — (224) 948‑5353 — media@baxter.com
đź“Ł REPORTING PROBLEMS
If anyone had issues using this product, they can report it through FDA MedWatch:
- Online form
- Mail‑in form
- Fax to 1‑800‑FDA‑0178
📸 PRODUCT PHOTOS
Container labels and carton labels are available on FDA’s site for identification.
đź“… INFO CURRENT AS OF: August 25, 2026